The results showed that the expression of CSTF2 in breast invasive carcinoma, head and neck cancer, and liver hepatocellular carcinoma was significantly higher than that in adjacent tissues; however, the difference was not significant in colon adenocarcinoma. This evidence concerns the gene CSTF2 and head and neck cancer.